| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Dovitinib |
|---|
| Description | Dovitinib (TKI258, CHIR258) is a multitargeted RTK inhibitor. MW: 392.43. Purity ≥98% by HPLC |
|---|
| Size | 5 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | Dovitinib, CHIR-258; CHIR 258; CHIR258; 1-amino-5-fluoro-3-(6-(4-methylpiperazin-1-yl)-1H-benzo[d]imidazol-2-yl)quinolin-2(1H)-one; (3Z)-4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1,3-dihydrobenzimidazol-2-ylidene]quinolin-2-one; TKI258; TKI-258; TKI 258; Multitargeted RTK inhibitor |
|---|
| Gene, Accession, CAS # | CAS: 405169-16-6 |
|---|
| Catalog # | B1614-5 |
|---|
| Price | |
|---|
| Order / More Info | Dovitinib from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|